Inger Helene Mattsby Baltzer
Directeur/Membre du Conseil chez Fungea AB
Profil
Inger Helene Mattsby Baltzer is the founder of PharmaSurgics In Sweden AB, which was founded in 2005.
She is currently a Director at Fungea AB.
Postes actifs de Inger Helene Mattsby Baltzer
| Sociétés | Poste | Début |
|---|---|---|
Fungea AB
 Fungea AB BiotechnologyHealth Technology Fungea AB engages in the development of tests to detect the presence of fungi, bacteria, or other microorganisms in humans and animals, food ingredients, or elsewhere in the environment. It specializes in commercial physical and biological research. The firm also develops probiotics and other methods to influence the microbial environment, production, and distribution of its products and consulting. The company was founded on June 19, 2006 and is headquartered in Nödinge, Sweden. | Directeur/Membre du Conseil | - |
Anciens postes connus de Inger Helene Mattsby Baltzer
| Sociétés | Poste | Fin |
|---|---|---|
PharmaSurgics In Sweden AB
 PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
PharmaSurgics In Sweden AB
PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Health Technology |
Fungea AB
Fungea AB BiotechnologyHealth Technology Fungea AB engages in the development of tests to detect the presence of fungi, bacteria, or other microorganisms in humans and animals, food ingredients, or elsewhere in the environment. It specializes in commercial physical and biological research. The firm also develops probiotics and other methods to influence the microbial environment, production, and distribution of its products and consulting. The company was founded on June 19, 2006 and is headquartered in Nödinge, Sweden. | Health Technology |
